swot-logo

Neurocrine Biosciences, Inc. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Neurocrine Biosciences, Inc. has 28 Strengths, 8 Weaknesses, 1 Opportunities and 3 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

MACD Crossover Above Signal Line

Price crossing above SMA20 today, and greater than SMA5

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Weekly Strategy: High Momentum Score Stocks (subscription)

Annual Profit Growth higher than Sector Profit Growth

High Momentum Scores (Technical Scores greater than 50)

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Week

Results Screener: Stocks with upcoming results which are seeing positive shifts in share price

MACD crossed above zero line previous end of day

MACD crossed above signal line previous end of day

Near 52 Week High

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Low Debt

Increasing Revenue every quarter for the past 2 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Increasing profits every quarter for the past 2 quarters

Top Gainers

RSI indicating price strength

Stocks near 52 Week High with Significant Volumes

Volume Shockers

High Volume, High Gain